Effects of 5-HT1B receptor ligands microinjected into the accumbal shell or core on the sensitization to cocaine in rats

European Neuropsychopharmacology

Volumn 12, Issue 5, 2002, Pages 387-396

  Przegaliński, Edmund ^a   Siwanowicz, Joanna ^a   Papla, Iwona ^a   Filip, Malgorzata ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT1B receptors; Behavioral sensitization; Cocaine; CP 93129; GR 55562; Nucleus accumbens; Rats

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; COCAINE; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIZATION; DRUG WITHDRAWAL; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BENZAMIDES; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PYRIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0036789603     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00052-4     Document Type: Article

References (53)

1. Andrews C.M., Lucki I. Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology. 155:2001;221-229.
2. 1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience. 82:1998;469-484.
3. 1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacology. 35:1996;1521-1529.
4. 1B binding sites in rat brain. Naunyn-Schmiedeberg′s Arch. Pharmacol. 347:1993;569-582.
5. Cadoni C., Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience. 90:1999;447-455.
6. Cadoni C., Di Chiara G. Differential changes in accumbens shell and core dopamine in behavioural sensitization to nicotine. Eur. J. Pharmacol. 387:2000;R23-R25.
7. Cadoni C., Solinas M., Di Chiara G. Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur. J. Pharmacol. 388:2000;69-76.
8. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitisation to amphetamine. Neuroscience. 65:1995;385-395.
9. 2C receptors. J. Pharmacol. Exp. Ther. 274:1995;1414-1424.
10. 1B receptor agonists. Neuropharmacology. 36:1997;373-381.
11. Cameron D.L., Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14:1994;6763-6767.
12. 1B receptors: a comparison of knockouts and antagonists. Pharmacol. Biochem. Behav. 67:2000;559-566.
13. 3H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br. J. Pharmacol. 130:2000;1927-1932.
14. 1B/D receptor ligands. Pharmacol. Ther. 62:1994;385-405.
15. De Vries T.J., Cools A.R., Shippenberg T.S. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport. 9:1998;1763-1768.
16. 1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats. J. Physiol. Pharmacol. 52:2001;249-263.
17. 1B receptors. Neuropsychopharmacology. 21:1999;268-284.
18. Guan X.M., McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23:1989;541-547.
19. 1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study. Neurosci. Lett. 225:1997;57-60.
20. Heidbreder C.A., Thompson A.C., Shippenberg T.S. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 278:1996;490-502.
21. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
22. Hedou G., Feldon J., Heidbreder C.A. Effects of cocaine on dopamine in subregions of the rat prefrontal cortex and their efferrents to the subterritories of the nucleus accumbens. Eur. J. Pharmacol. 372:1999;143-155.
23. 1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur. J. Pharmacol. 209:1991;249-252.
24. B synaptic potential in rat dopamine neurons. J. Neurosci. 12:1992;2000-2006.
25. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:1988;485-492.
26. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
27. Kalivas P.W., Pierce R.C., Cornish J., Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Pharmacol. 12:1998;49-53.
28. King G.R., Kuhn C., Ellinwood E.H. Jr. Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology. 111:1993;179-184.
29. 3 receptor antagonist, and cocaine. Psychopharmacology. 130:1997;159-165.
30. 3 receptor antagonist. Eur. J. Pharmacol. 394:2000;97-101.
31. 1B receptor agonist, CP-94,253. Drug Dev. Res. 26:1992;241-250.
32. Kuczenski R., Segal D.S. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262:1992;1085-1094.
33. 2 receptor antagonists in terms of ambulation in mice. Pharmacol. Biochem. Behav. 51:1995;799-805.
34. 1B antagonists by chemical modulation of 3-[3-(N,N-dimethylamino)propyl]-4-hydroxy-N-[4-(pyridin-4-yl)phenyl]benzamide (GR 55562). J. Med. Chem. 40:1997;3542-3550.
35. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J. Med. Chem. 33:1990;2087-2093.
36. 2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology. 114:1994;239-242.
37. Mattingly B.A., Rowlett J.K., Ellison T., Rase K. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol. Biochem. Behav. 53:1996;481-486.
38. 1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine. Synapse. 32:1999;132-135.
39. 1B receptor stimulation enhances cocaine reinforcement. J. Neurosci. 18:1998;10078-10089.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, New York.
41. Pierce R.C., Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275:1995;1019-1029.
42. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
43. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA. 92:1995;12304-12308.
44. Price G.W., Roberts C., Watson J., Burton M., Mulholland K., Middlemiss D.N., Jones B.J. Species differences in 5-HT autoreceptors. Behav. Brain Res. 73:1996;79-82.
45. 1B receptor ligands on cocaine sensitization in rats. Behav. Pharmacol. 12:2001;109-116.
46. 1A receptors inhibits amphetamine sensitization in mice. Life Sci. 66:2000;1011-1019.
47. 1B receptors in the sensitization to amphetamine in mice. Eur. J. Pharmacol. 422:2001;91-99.
48. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46:1990;635-645.
49. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Bull. 18:1993;247-291.
50. Segal D.S., Geyer M.A., Schuckit M.A. An evaluation of animal models. Youdim M.B.H., Lovenberg W., Sharman D.F., Lagnado J.R., Essays in Neurochemistry and Neuropharmacology. 1981;95-129 Wiley, London.
51. White F.J., Joshi A., Koeltzow T.E., Hu X.-T. Dopamine receptor antagonists fail to prevent induction of cocaine sensitisation. Neuropsychopharmacology. 18:1998;26-40.
52. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. TiPS. 13:1992;193-200.
53. 1B/1D receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur. J. Pharmacol. 418:2001;55-64.